VERASTEM INC (VSTM) Fundamental Analysis & Valuation

NASDAQ:VSTM • US92337C2035

Current stock price

6.34 USD
+0.01 (+0.16%)
At close:
6.3 USD
-0.04 (-0.63%)
After Hours:

This VSTM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. VSTM Profitability Analysis

1.1 Basic Checks

  • In the past year VSTM has reported negative net income.
  • In the past year VSTM has reported a negative cash flow from operations.
  • VSTM had negative earnings in each of the past 5 years.
  • VSTM had a negative operating cash flow in each of the past 5 years.
VSTM Yearly Net Income VS EBIT VS OCF VS FCFVSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M

1.2 Ratios

  • VSTM has a Return On Assets of -85.00%. This is in the lower half of the industry: VSTM underperforms 70.93% of its industry peers.
  • VSTM has a worse Return On Equity (-366.23%) than 75.00% of its industry peers.
Industry RankSector Rank
ROA -85%
ROE -366.23%
ROIC N/A
ROA(3y)-90.67%
ROA(5y)-83.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSTM Yearly ROA, ROE, ROICVSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K

1.3 Margins

  • Looking at the Gross Margin, with a value of 82.86%, VSTM belongs to the top of the industry, outperforming 86.24% of the companies in the same industry.
  • VSTM's Gross Margin has improved in the last couple of years.
  • VSTM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.08%
GM growth 5Y5.71%
VSTM Yearly Profit, Operating, Gross MarginsVSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. VSTM Health Analysis

2.1 Basic Checks

  • VSTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, VSTM has more shares outstanding
  • VSTM has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, VSTM has an improved debt to assets ratio.
VSTM Yearly Shares OutstandingVSTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
VSTM Yearly Total Debt VS Total AssetsVSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • VSTM has an Altman-Z score of -6.27. This is a bad value and indicates that VSTM is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -6.27, VSTM is doing worse than 66.86% of the companies in the same industry.
  • VSTM has a Debt/Equity ratio of 1.42. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.42, VSTM is doing worse than 78.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Altman-Z -6.27
ROIC/WACCN/A
WACC9.43%
VSTM Yearly LT Debt VS Equity VS FCFVSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

2.3 Liquidity

  • VSTM has a Current Ratio of 3.09. This indicates that VSTM is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 3.09, VSTM is not doing good in the industry: 61.82% of the companies in the same industry are doing better.
  • A Quick Ratio of 3.07 indicates that VSTM has no problem at all paying its short term obligations.
  • VSTM has a Quick ratio of 3.07. This is in the lower half of the industry: VSTM underperforms 60.27% of its industry peers.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 3.07
VSTM Yearly Current Assets VS Current LiabilitesVSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. VSTM Growth Analysis

3.1 Past

  • VSTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.43%, which is quite good.
  • VSTM shows a strong growth in Revenue. In the last year, the Revenue has grown by 209.14%.
  • Measured over the past years, VSTM shows a very negative growth in Revenue. The Revenue has been decreasing by -18.97% on average per year.
EPS 1Y (TTM)13.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.41%
Revenue 1Y (TTM)209.14%
Revenue growth 3Y128.24%
Revenue growth 5Y-18.97%
Sales Q2Q%N/A

3.2 Future

  • VSTM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.92% yearly.
  • VSTM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 81.07% yearly.
EPS Next Y44.79%
EPS Next 2Y32.43%
EPS Next 3Y22.57%
EPS Next 5Y21.92%
Revenue Next Year280.05%
Revenue Next 2Y155.85%
Revenue Next 3Y112.31%
Revenue Next 5Y81.07%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VSTM Yearly Revenue VS EstimatesVSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
VSTM Yearly EPS VS EstimatesVSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -5 -10 -15 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. VSTM Valuation Analysis

4.1 Price/Earnings Ratio

  • VSTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year VSTM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSTM Price Earnings VS Forward Price EarningsVSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSTM Per share dataVSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • VSTM's earnings are expected to grow with 22.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.43%
EPS Next 3Y22.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VSTM Dividend Analysis

5.1 Amount

  • VSTM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VSTM Fundamentals: All Metrics, Ratios and Statistics

VERASTEM INC

NASDAQ:VSTM (4/16/2026, 8:05:29 PM)

After market: 6.3 -0.04 (-0.63%)

6.34

+0.01 (+0.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)05-11
Inst Owners84.02%
Inst Owner Change0%
Ins Owners0.58%
Ins Owner Change1.29%
Market Cap556.91M
Revenue(TTM)30.91M
Net Income(TTM)-209.47M
Analysts85.33
Price Target17.05 (168.93%)
Short Float %19.48%
Short Ratio8.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-49.21%
Min EPS beat(2)-108.2%
Max EPS beat(2)9.78%
EPS beat(4)2
Avg EPS beat(4)-14.72%
Min EPS beat(4)-108.2%
Max EPS beat(4)48.42%
EPS beat(8)4
Avg EPS beat(8)-6.99%
EPS beat(12)6
Avg EPS beat(12)-10.57%
EPS beat(16)8
Avg EPS beat(16)-5.87%
Revenue beat(2)2
Avg Revenue beat(2)49.3%
Min Revenue beat(2)3.86%
Max Revenue beat(2)94.73%
Revenue beat(4)3
Avg Revenue beat(4)21.35%
Min Revenue beat(4)-100%
Max Revenue beat(4)94.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.54%
PT rev (3m)4.46%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)18.25%
EPS NY rev (1m)4.93%
EPS NY rev (3m)12.24%
Revenue NQ rev (1m)3.22%
Revenue NQ rev (3m)29.6%
Revenue NY rev (1m)8.04%
Revenue NY rev (3m)9.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 18.01
P/FCF N/A
P/OCF N/A
P/B 9.74
P/tB 13.66
EV/EBITDA N/A
EPS(TTM)-3.03
EYN/A
EPS(NY)-1.67
Fwd EYN/A
FCF(TTM)-1.68
FCFYN/A
OCF(TTM)-1.57
OCFYN/A
SpS0.35
BVpS0.65
TBVpS0.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -85%
ROE -366.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.86%
FCFM N/A
ROA(3y)-90.67%
ROA(5y)-83.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.08%
GM growth 5Y5.71%
F-Score6
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1321.98%
Cap/Sales 31.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.09
Quick Ratio 3.07
Altman-Z -6.27
F-Score6
WACC9.43%
ROIC/WACCN/A
Cap/Depr(3y)476.56%
Cap/Depr(5y)304.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.41%
EPS Next Y44.79%
EPS Next 2Y32.43%
EPS Next 3Y22.57%
EPS Next 5Y21.92%
Revenue 1Y (TTM)209.14%
Revenue growth 3Y128.24%
Revenue growth 5Y-18.97%
Sales Q2Q%N/A
Revenue Next Year280.05%
Revenue Next 2Y155.85%
Revenue Next 3Y112.31%
Revenue Next 5Y81.07%
EBIT growth 1Y-47.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y45.93%
EBIT Next 5Y14.17%
FCF growth 1Y-40.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.25%
OCF growth 3YN/A
OCF growth 5YN/A

VERASTEM INC / VSTM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for VERASTEM INC?

ChartMill assigns a fundamental rating of 2 / 10 to VSTM.


Can you provide the valuation status for VERASTEM INC?

ChartMill assigns a valuation rating of 1 / 10 to VERASTEM INC (VSTM). This can be considered as Overvalued.


How profitable is VERASTEM INC (VSTM) stock?

VERASTEM INC (VSTM) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for VSTM stock?

The Earnings per Share (EPS) of VERASTEM INC (VSTM) is expected to grow by 44.79% in the next year.